Trial medicine and placebo for Bristol NHS trust will come from MIAA
- Bristol NHS Foundation Trust
- Direct award
- 1 December 2026 to 31 December 2032
MIAA will make an investigational medicinal product (IMP) and placebo for Bristol NHS Foundation Trust. Both have to be made in aseptic conditions. The process is highly specialised, and the trust says the UK firms able to offer it are limited.
While applying for grant funding, the trust asked five other NHS pharmacy aseptic services for a quote. None of them could meet the required specification.
The trust then awarded the £152,440 contract directly to MIAA in October 2026. It is due to run to December 2032.
Contract ends December 2032
- What
- Aseptic compounding, specials and contract pharmaceutical manufacturing
- Supplier
- MIAA
- Value
- £152,440
- How it was bought
- Direct award
- Dates and next
- Dec 2026 to Dec 2032